vimarsana.com
Home
Live Updates
Crossject provides strategic update on priorities for 2024 : vimarsana.com
Crossject provides strategic update on priorities for 2024
Focusing on regulatory filings and accelerating U.S. commercialization efforts Contract of up to $155 million with BARDA for U.S. stockpiling continues to advance Dijon, France February 6, 2024...
Related Keywords
New Zealand ,
France ,
Australia ,
United States ,
Didier Morin ,
Sophie Baumont ,
Natasha Drapeau ,
Patrick Alexandre ,
Human Services ,
Development Authority ,
Us Department Of Health ,
Syneos Health ,
Euronext ,
Pharmaceuticals For Australia ,
Cohesion Bureau ,
Biomedical Advanced Research ,
Drug Administration ,
Administration For Strategic Preparedness ,
Us Biomedical Advanced Research ,
France February ,
Strategic Preparedness ,
Emergency Use Authorization ,
Chief Operating Officer ,
Industrial Director ,
Henri De Parseval ,
Advanced Research ,
vimarsana.com © 2020. All Rights Reserved.